These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36342727)

  • 1. Concurrent Interstitial Granulomatous Dermatitis and TNF-α Antagonist-Induced Lupus Syndrome Secondary to Adalimumab for Crohn's Disease.
    Adusumilli N; Aronica J; Glass F; Friedman A
    J Drugs Dermatol; 2022 Nov; 21(11):1256-1257. PubMed ID: 36342727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha antagonist induced lupus on three different agents.
    Mudduluru BM; Shah S; Shamah S; Swaminath A
    Postgrad Med; 2017 Mar; 129(2):304-306. PubMed ID: 27748629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo Anti-TNF-α-induced Congestive Heart Failure in a Patient With Turner Syndrome and Crohn's Disease.
    Keating E; Kelleher TB; Lahiff C
    Inflamm Bowel Dis; 2020 Nov; 26(12):e161-e162. PubMed ID: 32619005
    [No Abstract]   [Full Text] [Related]  

  • 4. Adalimumab induced psoriasis in a Crohn's disease patient: A case report.
    Alenizi D
    J Pak Med Assoc; 2024 Jul; 74(7):1361-1363. PubMed ID: 39028072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab in pediatric Crohn's disease.
    Patel AS; Suarez LD; Rosh JR
    Immunotherapy; 2016 Feb; 8(2):127-33. PubMed ID: 26787222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.
    West ES; Nanda K; Ofodile O; Rutledge J; Brandling-Bennett HA
    Pediatr Dermatol; 2015; 32(4):e140-4. PubMed ID: 25845414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive antiphospholipid antibodies and pulmonary embolism in a patient with adalimumab-induced lupus.
    Uehara M; Matsushita S; Aochi S; Yamamoto M
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):68-73. PubMed ID: 36208152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis.
    Guerin M; Haettich B; Bara C; Artru L; Prophette B; Célérier P; Maillard H
    Rheumatol Int; 2012 Sep; 32(9):2937-40. PubMed ID: 21800115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
    Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
    Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
    Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: results of a systematic review.
    Fidder HH; Singendonk MM; van der Have M; Oldenburg B; van Oijen MG
    World J Gastroenterol; 2013 Jul; 19(27):4344-50. PubMed ID: 23885145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB5: An Adalimumab Biosimilar.
    Frampton JE
    BioDrugs; 2018 Oct; 32(5):507-510. PubMed ID: 30251234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature.
    Salvatori S; Marafini I; Monteleone G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1046-e1050. PubMed ID: 33905217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-α Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis.
    Salvador-Rodriguez L; Montero-Vílchez T; Arias-Santiago S; Molina-Leyva A
    Dermatology; 2020; 236(4):307-313. PubMed ID: 32135533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tubulointerstitial nephritis in an HLA-B27-positive patient with axial spondyloarthritis being treated with adalimumab.
    Castro Corredor D; Sánchez de la Nieta MD; de Lara Simón IM
    Reumatol Clin (Engl Ed); 2019; 15(3):179-181. PubMed ID: 28624373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
    Condamina M; Diaz E; Jamart C; Loget J; Durlach A; Salmon JH; Cadiot G; Viguier M
    J Crohns Colitis; 2020 May; 14(4):538-542. PubMed ID: 31589303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced lupus with leukocytoclastic vasculitis: a rare expression associated with adalimumab.
    Amarante CF; Acedo LM; Rabay FM; Campos Bdo E; Lira ML; Mandelbaum SH
    An Bras Dermatol; 2015; 90(3 Suppl 1):121-4. PubMed ID: 26312693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center.
    Mori M; Tobita R; Egusa C; Maeda T; Abe N; Kawakami H; Mae K; Matsumoto Y; Kawachi Y; Okubo Y
    J Dermatol; 2021 Nov; 48(11):1745-1753. PubMed ID: 34409641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.